WO2002085943A3 - Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees - Google Patents

Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees Download PDF

Info

Publication number
WO2002085943A3
WO2002085943A3 PCT/EP2002/003320 EP0203320W WO02085943A3 WO 2002085943 A3 WO2002085943 A3 WO 2002085943A3 EP 0203320 W EP0203320 W EP 0203320W WO 02085943 A3 WO02085943 A3 WO 02085943A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
gene
vectors containing
abcc12
abcc12 gene
Prior art date
Application number
PCT/EP2002/003320
Other languages
English (en)
Other versions
WO2002085943A2 (fr
Inventor
Marie-Francoise Rosier-Montus
Catherine Prades
Isabelle Arnould-Reguigne
Patrice Denefle
Michael Dean
Rando Allikmets
Original Assignee
Aventis Pharma Sa
Us Gov Health & Human Serv
Marie-Francoise Rosier-Montus
Catherine Prades
Isabelle Arnould-Reguigne
Patrice Denefle
Michael Dean
Rando Allikmets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Us Gov Health & Human Serv, Marie-Francoise Rosier-Montus, Catherine Prades, Isabelle Arnould-Reguigne, Patrice Denefle, Michael Dean, Rando Allikmets filed Critical Aventis Pharma Sa
Priority to CA002439693A priority Critical patent/CA2439693A1/fr
Priority to EP02712956A priority patent/EP1370585A2/fr
Priority to JP2002583469A priority patent/JP2004537983A/ja
Publication of WO2002085943A2 publication Critical patent/WO2002085943A2/fr
Publication of WO2002085943A3 publication Critical patent/WO2002085943A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne un nouveau gène humain appelé ABCC12 ainsi que les ADNc codant les nouvelles isoformes courtes et longues des protéines ABCC12. Par ailleurs, l'invention concerne des vecteurs et des cellules hôtes recombinées contenant ces acides nucléiques, des sondes nucléotidiques et des amorces, ainsi que des moyens de détection de polymorphismes et de mutations dans le gène ABCC12 ou dans les isoformes des protéines correspondantes, produites par la forme allélique du gène ABCC12.
PCT/EP2002/003320 2001-03-05 2002-03-05 Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees WO2002085943A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002439693A CA2439693A1 (fr) 2001-03-05 2002-03-05 Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees
EP02712956A EP1370585A2 (fr) 2001-03-05 2002-03-05 Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees
JP2002583469A JP2004537983A (ja) 2001-03-05 2002-03-05 ヒトａｂｃｃ１２遺伝子の核酸、このような核酸を含むベクター、およびこれらの使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27275901P 2001-03-05 2001-03-05
US60/272,759 2001-03-05

Publications (2)

Publication Number Publication Date
WO2002085943A2 WO2002085943A2 (fr) 2002-10-31
WO2002085943A3 true WO2002085943A3 (fr) 2003-04-17

Family

ID=23041149

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/003320 WO2002085943A2 (fr) 2001-03-05 2002-03-05 Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees

Country Status (4)

Country Link
EP (1) EP1370585A2 (fr)
JP (1) JP2004537983A (fr)
CA (1) CA2439693A1 (fr)
WO (1) WO2002085943A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2439702A1 (fr) * 2001-03-05 2002-09-19 Aventis Pharma S.A. Acides nucleiques du gene abcc11 humain, vecteurs contenant lesdits acides nucleiques et leurs utilisations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057214A2 (fr) * 2000-02-03 2001-08-09 Lexicon Genetics Incorporated Nouvelles proteines transporteuses humaines et polynucleotides codant pour ces proteines
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2002072632A2 (fr) * 2001-03-05 2002-09-19 Aventis Pharma S.A. Acides nucleiques du gene abcc11 humain, vecteurs contenant lesdits acides nucleiques et leurs utilisations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057214A2 (fr) * 2000-02-03 2001-08-09 Lexicon Genetics Incorporated Nouvelles proteines transporteuses humaines et polynucleotides codant pour ces proteines
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2002072632A2 (fr) * 2001-03-05 2002-09-19 Aventis Pharma S.A. Acides nucleiques du gene abcc11 humain, vecteurs contenant lesdits acides nucleiques et leurs utilisations

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
ALLIKMETS R ET AL: "Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the Expressed Sequence Tags Database", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 5, no. 10, 1996, pages 1649 - 1655, XP002120400, ISSN: 0964-6906 *
BENNETT LYNDA B ET AL: "A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16.", NEUROLOGY, vol. 54, no. 1, 11 January 2000 (2000-01-11), pages 125 - 130, XP009004537, ISSN: 0028-3878 *
DATABASE EMBL [online] 1 February 2000 (2000-02-01), STRAUSBERG R: "hd13d01.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2909377 3' similar to TR:O14517 O14517 SMRP. ;, mRNA sequence.", XP002228124, Database accession no. AW341683 *
DATABASE EMBL [online] 21 May 1999 (1999-05-21), BRUCE D ET AL.,: "Homo sapiens chromosome 16 clone RP11-264A16, complete sequence.", XP002228126, Database accession no. AC007600 *
DATABASE GENESEQ [online] 13 February 2002 (2002-02-13), DRMANAC RT. ET AL.: "DNA encoding novel human diagnostic protein #25888.", XP002228127, Database accession no. AAS90084 *
DATABASE GENESEQ [online] 18 February 2002 (2002-02-18), DRMANAC RT ET AL.,: "Novel human diagnostic protein #25888.", XP002228128, Database accession no. ABG25897 *
DATABASE SWISS-PROT [online] 15 July 1998 (1998-07-15), BELINSKY MG, ET AL.,: "Multidrug resistance-associated protein 5 (Multi-specific organic anion tranporter-C) (MOAT-C) (pABC11) (SMRP).", XP002228125, Database accession no. O14517 *
TAMMUR J ET AL: "Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 273, no. 1, 25 July 2001 (2001-07-25), pages 89 - 96, XP004296790, ISSN: 0378-1119 *
TOMITA HIRO-AKI ET AL: "Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1.", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 65, no. 6, December 1999 (1999-12-01), pages 1688 - 1697, XP002228122, ISSN: 0002-9297 *
YABUUCHI HIKARU ET AL: "Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 288, no. 4, 9 November 2001 (2001-11-09), pages 933 - 939, XP002228123, ISSN: 0006-291X *

Also Published As

Publication number Publication date
EP1370585A2 (fr) 2003-12-17
JP2004537983A (ja) 2004-12-24
CA2439693A1 (fr) 2002-10-31
WO2002085943A2 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
EP1005540A4 (fr) Proteines ikk-beta, acides nucleiques et procedes
EP1757689A3 (fr) Famille de gènes mammaliens de protéines inhibant l'apoptose (iap), amorces, sondes et procédés de détection
WO2005003296A3 (fr) Proteines hybrides d'albumine
WO2002085940A3 (fr) Polynucleotides et polypeptides du gene de l'erythropoietine (epo)
WO2000027994A3 (fr) Sequence genomique de chlamydia pneumoniae
WO2002086144A3 (fr) Compositions et procedes destines au clonage recombinant de molecules d'acides nucleiques
WO1998056927A3 (fr) Acides nucleiques codant des polypeptides a fonction protease
CY1107335T1 (el) ΝΕΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ ΤΟΥ ΓΟΝΙΔΙΟΥ IFNα-17
WO2003030821A3 (fr) Proteines de fusion d'albumine
CA2281895A1 (fr) Ikb kinases
WO2007060213A3 (fr) Polypeptides d’erythropoietine et leurs utilisations
DE69808743T2 (de) Netrinrezeptoren
WO2002048329A3 (fr) Caspase 3 derivee d'une membrane, compositions contenant cette caspase et procedes d'utilisation associes
CA2294566A1 (fr) Proteines ikk-.alpha., acides nucleiques et procedes
WO2006017355A3 (fr) Variants d'aprotinine ameliores
WO2002079249A3 (fr) Nouveaux polynucleotides et nouveaux polypeptides du gene ifn$g(a)-21
EP1284297A3 (fr) Identification et utilisation des molécules impliquées dans la douleur
WO2002064827A3 (fr) Acides nucleiques du gene humain abca12, vecteurs contenant ces acides nucleiques, et utilisations associees
WO2003029422A3 (fr) Gene du syndrome de noonan
WO2002095067A3 (fr) Nouveaux polynucleotides et polypeptides du gene ifnα-14
WO2002102316A3 (fr) Histone-deacetylase et procedes d'utilisation correspondants
WO2002046458A3 (fr) Acides nucleiques des genes humains abca5, abca6, abca9 et abca10, vecteurs contenant de tels acides nucleiques et leurs utilisations
WO2003000896A3 (fr) Nouveaux polynucleotides et polypeptides du gene ifn$g(a)-5
WO2002085943A3 (fr) Acides nucleiques du gene abcc12 humain, vecteurs contenant ces acides nucleiques et utilisations associees
WO2002072632A3 (fr) Acides nucleiques du gene abcc11 humain, vecteurs contenant lesdits acides nucleiques et leurs utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2439693

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002583469

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002712956

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002712956

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002712956

Country of ref document: EP